Tumor-Specific Major Histocompatibility-II Expression Predicts Benefit to Anti–PD-1/L1 Therapy in Patients With HER2-Negative Primary Breast Cancer

Paula I. Gonzalez-ericsson; Julia D. Wulfkhule; Rosa I. Gallagher; Xiaopeng Sun; Margaret L. Axelrod; Quanhu Sheng; Na Luo; Henry Gomez; Violeta Sanchez; Melinda Sanders; Lajos Pusztai; Emanuel Petricoin; Kim R.m. Blenman; David A Potter; Justin M. Balko

doi:10.1158/1078-0432.CCR-21-0607

Tumor-Specific Major Histocompatibility-II Expression Predicts Benefit to Anti–PD-1/L1 Therapy in Patients With HER2-Negative Primary Breast Cancer

Paula I. Gonzalez-ericsson, Julia D. Wulfkhule, Rosa I. Gallagher, Xiaopeng Sun, Margaret L. Axelrod, Quanhu Sheng, Na Luo, Henry Gomez, Violeta Sanchez, Melinda Sanders, Lajos Pusztai, Emanuel Petricoin, Kim R.m. Blenman, David A Potter, Justin M. Balko

Research output: Contribution to journal › Article › peer-review

53 Scopus citations

Original language	English (US)
Pages (from-to)	5299-5306
Journal	Clinical Cancer Research
Volume	27
Issue number	19
DOIs	https://doi.org/10.1158/1078-0432.CCR-21-0607
State	Published - Oct 1 2021

PubMed: MeSH publication types

Journal Article
Research Support, N.I.H., Extramural
Research Support, Non-U.S. Gov't

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Publisher link

10.1158/1078-0432.CCR-21-0607

https://aacrjournals.org/clincancerres/article/27/19/5299/671701/Tumor-Specific-Major-Histocompatibility-II

Find It

Find It at U of M Libraries

Cite this

Gonzalez-ericsson, P. I., Wulfkhule, J. D., Gallagher, R. I., Sun, X., Axelrod, M. L., Sheng, Q., Luo, N., Gomez, H., Sanchez, V., Sanders, M., Pusztai, L., Petricoin, E., Blenman, K. R. M., Potter, D. A., & Balko, J. M. (2021). Tumor-Specific Major Histocompatibility-II Expression Predicts Benefit to Anti–PD-1/L1 Therapy in Patients With HER2-Negative Primary Breast Cancer. Clinical Cancer Research, 27(19), 5299-5306. https://doi.org/10.1158/1078-0432.CCR-21-0607

Gonzalez-ericsson, PI, Wulfkhule, JD, Gallagher, RI, Sun, X, Axelrod, ML, Sheng, Q, Luo, N, Gomez, H, Sanchez, V, Sanders, M, Pusztai, L, Petricoin, E, Blenman, KRM, Potter, DA & Balko, JM 2021, 'Tumor-Specific Major Histocompatibility-II Expression Predicts Benefit to Anti–PD-1/L1 Therapy in Patients With HER2-Negative Primary Breast Cancer', Clinical Cancer Research, vol. 27, no. 19, pp. 5299-5306. https://doi.org/10.1158/1078-0432.CCR-21-0607

@article{7a69b5e738db4b658d27c46550d0c861,

title = "Tumor-Specific Major Histocompatibility-II Expression Predicts Benefit to Anti–PD-1/L1 Therapy in Patients With HER2-Negative Primary Breast Cancer",

author = "Gonzalez-ericsson, {Paula I.} and Wulfkhule, {Julia D.} and Gallagher, {Rosa I.} and Xiaopeng Sun and Axelrod, {Margaret L.} and Quanhu Sheng and Na Luo and Henry Gomez and Violeta Sanchez and Melinda Sanders and Lajos Pusztai and Emanuel Petricoin and Blenman, {Kim R.m.} and Potter, {David A} and Balko, {Justin M.}",

year = "2021",

month = oct,

day = "1",

doi = "10.1158/1078-0432.CCR-21-0607",

language = "English (US)",

volume = "27",

pages = "5299--5306",

journal = "Clinical Cancer Research",

issn = "1078-0432",

publisher = "American Association for Cancer Research Inc.",

number = "19",

}

TY - JOUR

T1 - Tumor-Specific Major Histocompatibility-II Expression Predicts Benefit to Anti–PD-1/L1 Therapy in Patients With HER2-Negative Primary Breast Cancer

AU - Gonzalez-ericsson, Paula I.

AU - Wulfkhule, Julia D.

AU - Gallagher, Rosa I.

AU - Sun, Xiaopeng

AU - Axelrod, Margaret L.

AU - Sheng, Quanhu

AU - Luo, Na

AU - Gomez, Henry

AU - Sanchez, Violeta

AU - Sanders, Melinda

AU - Pusztai, Lajos

AU - Petricoin, Emanuel

AU - Blenman, Kim R.m.

AU - Potter, David A

AU - Balko, Justin M.

PY - 2021/10/1

Y1 - 2021/10/1

U2 - 10.1158/1078-0432.CCR-21-0607

DO - 10.1158/1078-0432.CCR-21-0607

M3 - Article

C2 - 34315723

SN - 1078-0432

VL - 27

SP - 5299

EP - 5306

JO - Clinical Cancer Research

JF - Clinical Cancer Research

IS - 19

ER -